BOSTON–(BUSINESS WIRE)–Ukko, Inc., a biotechnology company re-inventing immunotherapy for allergic diseases, today announced a summary of 2025 operational achievements and provided a strategic outlook for 2026.
Read more here.
BOSTON–(BUSINESS WIRE)–Ukko, Inc., a biotechnology company re-inventing immunotherapy for allergic diseases, today announced a summary of 2025 operational achievements and provided a strategic outlook for 2026.
Read more here.
![[Ravin AI in PR Newswire] Hertz and Ravin AI Partner on AI-powered Vehicle Inspection Pilot](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
